ArticleEuropean journal of haematology2026
The Effect of Polycythemia Vera on Pregnancy Complications. The Analysis of an American Population Database With Over 9 Million Deliveries.
Article in European journal of haematology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectivesPolycythemia Vera (PV) is characterized by overproduction of erythrocytes, leading to a hypercoagulable state. Evidence regarding associations between PV and pregnancy outcomes is limited. The aim of our study was to provide robust evidence regarding the prevalence of pregnancy complications in women with PV.
methodsWe conducted a retrospective cohort study using the HCUP-NIS database, a large American database, between 2004 and 2014. Pregnancies in women with PV were identified via ICD-9 codes. All other pregnancies formed the control group.
resultsOur cohort included 104 pregnancies with PV and 9 096 684 controls. Baseline characteristics associated with PV included older age, white race, insurance through Medicaid, tobacco smoking during pregnancy, chronic hypertension, multiple gestation, and thyroid disease. Results indicated that PV was significantly associated with preeclampsia (aOR = 2.27; 95% CI = 1.04-4.97), preterm premature rupture of membranes (aOR = 4.47; 95% CI = 1.78-11.21), blood transfusion (aOR = 3.34; 95% CI = 1.17-9.55), baby with small for gestational age (aOR = 3.31; 95% CI = 1.55-7.08), and congenital anomalies (aOR = 10.93; 95% CI = 4.40-27.11). Maternal death (aOR = 108.79; 95% CI = 14.37-823.88), wound complications (aOR = 4.53; 95% CI = 1.10-18.69), and intrauterine fetal demise (aOR = 4.80; 95% CI = 1.17-19.70) were statistically significant but must be interpreted cautiously due to rarity. Other outcomes did not differ.
conclusionsPV is associated with several pregnancy complications. Women with PV should receive assiduous care during pregnancy to prevent these complications.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.